| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 26 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 2 | TACROLIMUS OINTMENT 0.1% | 25 |
| 3 | MYCOPHENOLATE MOFETIL | 15 |
| 4 | METHYLPREDNISOLONE | 14 |
| 5 | PREDNISOLONE | 14 |
| 6 | PREDNISOLONE ORAL | 14 |
| 7 | PREDNISOLONE ORAL SOLUTION | 14 |
| 8 | PREDNISONE | 12 |
| 9 | AZATHIOPRINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | STREPTOMYCIN | 1 | 0.0009 |
| 1 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 2 | MEFENAMIC ACID | 1 | 0.0005 |
| 3 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 4 | RIFAMPICIN | 2 | 0.0002 |
| 5 | TACROLIMUS OINTMENT 0.1% | 25 | 0.0002 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 | 0.0002 |
| 7 | TACROLIMUS | 26 | 0.0002 |
| 8 | MYCOPHENILIC ACID | 3 | 0.0001 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 2 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 6 | Purine Antimetabolite [EPC] | 3 | 0.0000 |
| 7 | Corticosteroid [EPC] | 28 | 0.0000 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |